Home Biotechnology BioAxone BioSciences, Inc.
B

BioAxone BioSciences, Inc.

Profile managed by Bizz Id

BioAxone

Estados Unidos 1-10 employees 2011

Description

Biopharmaceutical company founded in 2011 in Cambridge, MA, dedicated to developing drug candidates for neurotrauma and neurovascular disorders. Pipeline: Rho inhibitor (BA-210/VX-210, Phase 2b/3 licensed to Vertex), BA-434 (sd-rxRNA for spinal cord injury), and ROCK2 inhibitor licensed to Neurelis.

Contact company

Register for free to see this company’s contact details and get in touch.

Register - Free